FDG PET scan of the body, frontal (left) and posterior (right) views, showing a tumor on the dorsal vertebrae, an osseous (bony) metastasis from prostate cancer. FDG (F-labeled 2-deoxyglucose) is a radiopharmaceutical used to differentiate between benign and cancerous tumors by reflecting glucose uptake. (c) Sovereign
Dimensions
3031 x 2835 pixels
Print Size @ 300 dpi
10 x 9 inches / 26 x 24 cm